The device market is one of the fastest growing markets. It is “expected to reach an estimated $36.1 billion worldwide by 2023 and is forecast to grow at a rate of 21.1% from 2018 to 2023” according to a new report from ResearchandMarkets.com. The main reason for this is for the need to reduce the costs in health care and the need to increase reliable patient self-monitoring for chronic disease.
Our focus is on epilepsy, COPD and other respiratory diseases.
Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 6, 2019 | Meet the Seda Pitch and Perfect Season 4 finalists that will battle for R300k prize | The Small Enterprise Development Agency (Seda) has announced the names of 20 startups that will next week battle on another for the chance to be named the winner of Seda Pitch and Perfect — and with it, technology incentives to the value of... |
| Apr 20, 2012 | Parkinson’s disease monitoring company secures $4.5M in new funding | Great Lakes’ Kinesia movement disorder assessment technology uses a ring-like sensor worn on a patient’s finger to measure motor symptoms and wirelessly transmit data on the severity of a patient’s tremors. Understanding the type and severi... |
Reviews 0
FAQ about Monichron (PTY) Ltd
When was Monichron (PTY) Ltd founded?
Monichron (PTY) Ltd was founded in 2014.
What has the press written about Monichron (PTY) Ltd?
Parsers VC has collected 3 articles mentioning Monichron (PTY) Ltd, among them “Meet the Seda Pitch and Perfect Season 4 finalists that will battle for R300k prize” (Sep 6, 2019) and “Parkinson’s disease monitoring company secures $4.5M in new funding” (Apr 20, 2012).
Is Monichron (PTY) Ltd still active?
Yes, Monichron (PTY) Ltd is active; its latest activity on Parsers VC dates from Sep 6, 2019.